438 related articles for article (PubMed ID: 25474039)
1. Cancer associated fibroblasts in hematological malignancies.
Raffaghello L; Vacca A; Pistoia V; Ribatti D
Oncotarget; 2015 Feb; 6(5):2589-603. PubMed ID: 25474039
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts in digestive tumors.
Huang L; Xu AM; Liu S; Liu W; Li TJ
World J Gastroenterol; 2014 Dec; 20(47):17804-18. PubMed ID: 25548479
[TBL] [Abstract][Full Text] [Related]
3. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
Peng Y; Li Z; Li Z
Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
[TBL] [Abstract][Full Text] [Related]
4. Emerging targets for hematological malignancies.
Cilloni D; Frassoni F; Saglio G
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
Alonso S; Jones RJ; Ghiaur G
Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
[TBL] [Abstract][Full Text] [Related]
6. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
7. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
Horne GA; Copland M
Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.
Weber CE; Kothari AN; Wai PY; Li NY; Driver J; Zapf MA; Franzen CA; Gupta GN; Osipo C; Zlobin A; Syn WK; Zhang J; Kuo PC; Mi Z
Oncogene; 2015 Sep; 34(37):4821-33. PubMed ID: 25531323
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin.
McDonald LT; LaRue AC
Int J Clin Exp Pathol; 2012; 5(9):863-73. PubMed ID: 23119103
[TBL] [Abstract][Full Text] [Related]
10. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment.
Kinugasa Y; Matsui T; Takakura N
Stem Cells; 2014 Jan; 32(1):145-56. PubMed ID: 24395741
[TBL] [Abstract][Full Text] [Related]
11. The bone marrow niche in support of breast cancer dormancy.
Walker ND; Patel J; Munoz JL; Hu M; Guiro K; Sinha G; Rameshwar P
Cancer Lett; 2016 Sep; 380(1):263-71. PubMed ID: 26546045
[TBL] [Abstract][Full Text] [Related]
12. Hematological malignancies: disease pathophysiology of leukemic stem cells.
Ramdass B; Chowdhary A; Koka PS
J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
[TBL] [Abstract][Full Text] [Related]
13. Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.
Sarkaria SM; Decker M; Ding L
Bioessays; 2018 Mar; 40(3):. PubMed ID: 29384206
[TBL] [Abstract][Full Text] [Related]
14. The hypoxia signalling pathway in haematological malignancies.
Irigoyen M; García-Ruiz JC; Berra E
Oncotarget; 2017 May; 8(22):36832-36844. PubMed ID: 28415662
[TBL] [Abstract][Full Text] [Related]
15. Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies.
Yoshida GJ; Azuma A; Miura Y; Orimo A
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067787
[No Abstract] [Full Text] [Related]
16. Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment.
Seke Etet PF; Vecchio L; Bogne Kamga P; Nchiwan Nukenine E; Krampera M; Nwabo Kamdje AH
Biochim Biophys Acta; 2013 Jan; 1835(1):1-10. PubMed ID: 22982245
[TBL] [Abstract][Full Text] [Related]
17. Cancer Microenvironment: What Can We Learn from the Stem Cell Niche.
Lacina L; Plzak J; Kodet O; Szabo P; Chovanec M; Dvorankova B; Smetana K
Int J Mol Sci; 2015 Oct; 16(10):24094-110. PubMed ID: 26473842
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles in hematological malignancies.
Litwińska Z; Łuczkowska K; Machaliński B
Leuk Lymphoma; 2019 Jan; 60(1):29-36. PubMed ID: 29745272
[TBL] [Abstract][Full Text] [Related]
19. MUC1 in hematological malignancies.
Stroopinsky D; Kufe D; Avigan D
Leuk Lymphoma; 2016 Nov; 57(11):2489-98. PubMed ID: 27347699
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment.
McDonald LT; Russell DL; Kelly RR; Xiong Y; Motamarry A; Patel RK; Jones JA; Watson PM; Turner DP; Watson DK; Soloff AC; Findlay VJ; LaRue AC
Neoplasia; 2015 May; 17(5):434-48. PubMed ID: 26025666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
